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Abstract 
Aims: Prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing in developing countries but its causes are 
not known. We aimed to ascertain the prevalence and determinants of NAFLD in a new largely unmedicated 
population-based cohort from the rapidly gentrifying region of Pinggu, China. Materials and methods: We randomized 
cluster sampled 4002 Pinggu residents aged 26-76 years. Data from 1238 men and 1928 women without significant 
alcohol drinking or hepatitis virus B or C infection were analyzed. NAFLD was defined using a liver-spleen ratio (L/S 
ratio) ≤1.1 on unenhanced abdominal computed tomography(CT) scanning. Results: 26.5% of men and 20.1% of 
women had NAFLD. NAFLD prevalence was highest in younger men and older women. In multivariate logistic 
regression models, higher body mass index, waist circumference, serum triglyceride, alanine transaminase, and 
hemoglobin A1c independently increased the odds of NAFLD in both men and women separately. Higher annual 
household income and systolic blood pressure for men and, higher serum uric acid and red meat intake and lower 
physical activity levels for women also independently associated with higher odds of NAFLD. Individuals with L/S ratio 
≤1.1 had linearly increasing rates of obesity, diabetes, and metabolic syndrome that paralleled fatty liver increase. 
Conclusions: NAFLD is common in a gentrifying Chinese population particularly in younger men of high socioeconomic 
status and older women with sedentary behavior who eat red meat. Demographic factors add independent risk of 
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 NAFLD above traditional metabolic risk factors. A CT L/S ratio of ≤1.1 identifies individuals at high risk of metabolic 
disease. 
 
Key words: Non-alcoholic fatty liver disease, diabetes, obesity, physical activity, red meat 
 
  
This article is protected by copyright. All rights reserved.
 Introduction 
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease that develops in the presence of more than 5% 
triglyceride content in the liver in the absence of excessive alcohol intake. NAFLD is a risk factor for both incident1,2 and 
prevalent3 cardiovascular disease independent of conventional risk factors. NAFLD also predisposes to cirrhosis4 and 
hepatocellular carcinoma5. NAFLD prevalence has increased over the last 30 years particularly in developed and now 
developing countries worldwide6,7 ; causes of this increase in prevalence are only now being elucidated. The 
prevalence of NAFLD in the population based on histology is not known as a biopsy cannot be justified in otherwise 
healthy individuals. NAFLD estimates in the population have been determined using non-invasive markers of the 
disease such as alanine aminotransferase (ALT) or imaging, most commonly ultrasound. Both of these methods 
however have been shown to be highly inaccurate for quantitating NAFLD. Magnetic resonance spectroscopy (MRS) 
and magnetic resonance imaging quantify liver fat well but are cumbersome and expensive to implement clinically in 
large populations. Computed Tomography (CT) allows for accurate quantification of liver fat while also being clinically 
available and cost effective to implement in large populations to estimate the prevalence of this disease. A CT liver 
spleen density ratio (L/S ratio) ≤ 1.1 corresponds to more than 30% liver steatosis found in a biopsy specimen among 
living donors for liver transplantation8. In small studies9-12, NAFLD has been associated with obesity and development 
of related metabolic diseases and some demographic and lifestyle factors, but whether those contribute to the disease 
independently of each other in large cohorts is not known. Further, the effects of rapid modernization associates with 
development of obesity and related metabolic disorders but what components of that gentrification contribute to 
disease is not known. 
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 Here we use CT to measure liver fat in a largely unmedicated population-based cohort outside of Beijing in Pinggu, 
China. We chose this area as it has undergone gentrification and within a limited geographic area contains individuals 
with diverse exposures that may be able to give us insights into what determinants in developing regions contribute to 
higher levels of NAFLD. In this population with measured NAFLD we also measured many metabolic and demographic 
variables and examined the relationship of these to NAFLD. 
 
Materials and methods 
Study Population 
We used two-stage cluster random sampling to recruit participants aged 25-74 years from 25 villages out of five towns 
and seven residents’ committees out of one street in Pinggu district located in Beijing China, from March 2012 to May 
2013. 5004 residents were invited and 3350 initially participated13. In the second round, the 5004 originally selected 
residents were re-invited to participate and 1579 residents were additionally invited between September 2013 to July 
2014 for a total of 6583 invited residents. A total of 4002 individuals aged 26-76 years were enrolled, which gave a 
response rate of 60.8%. We excluded individuals who were hepatitis B or C positive (n=139), had a history of hepatitis 
B infection (n=1), had significant alcohol consumption [men > 210 g/week or women > 140 g/week14] (n=656), were 
missing a CT scan [including 4 women who planned to conceive and 3 with positive β-human chorionic gonadotropin] 
(n=18) or glucose (n=5) or physical activity (PA) (n=17) data. We analyzed 3166 individuals with complete data. 
The Pinggu metabolic disease study was approved by the ethics committees of Peking University Medical Center and 
University of Michigan. All participants gave written informed consent. 
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Non-laboratory assessments 
Participants were interviewed by trained doctors and nurses in the local clinics. Height and weight were measured 
when participants standing without shoes and light clothing. Body mass index (BMI) was calculated as weight divided 
by height squared (kg/m2). Waist circumference was measured at the middle point level between lower rib margin and 
the iliac crest. Blood pressure was measured three times after 10min resting and the mean of the three measures was 
used. Education was divided into elementary school or lower, middle school, college or higher education. Annual 
household income was divided into <25000, ≥25000 and <75000, ≥75000 Chinese Yuan (CNY, 1000 CNY=155 USD) 
and response as “Don’t know”. Long-form International Physical Activity Questionnaire15 was administered to classify 
the PA level. Participants reported the frequency and duration of walking, moderate and vigorous activities during work, 
transportation, domestic/yard work, and leisure time in the previous seven days. PA scores expressed as metabolic 
equivalents (MET)-minutes/week were calculated for intensity-specific PAs. PA level was classified into low, moderate, 
and high16. Smoking status was divided into non-smoker, ex-smoker if smoking was stopped or averaged < 1 cigarette 
daily and current smoker if averaged ≥ 1 cigarette daily. An interviewer-administered 103-item food frequency 
questionnaire containing questions about meat and alcohol consumption was used. Participants reported the intake 
frequency and the amount of food during the past year on a daily, weekly, monthly or yearly basis. Red meat intake 
was defined as the total amount of pork, beef and mutton intake per week which was divided into low consumption and 
high consumption according to the median amount. Food frequency questionnaire (FFQ) was validated before the 
survey. There was a positive linear relationship between FFQ and 24hr food recall for meat intake (Spearman 
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 Correlation 0.18) which indicates good agreement (Guan et al unpublished). For assessing alcohol consumption 
(g/week), ethanol content was assumed to be 5.3% by volume for beer, 12.9% by volume for wine, 30.8% by weight for 
low-alcohol liquor and 50.1% by weight for high-alcohol liquor. Significant alcohol consumption was defined as > 210 
g/week in men and > 140 g/week in women14. Individuals with significant alcohol consumption were excluded from the 
data analysis. Alcohol consumption was categorized into 0, > 0 and ≤ 140, > 140 and ≤ 210 g/week in men and 0, > 0 
and ≤ 70, > 70 and ≤ 140 g/week in women.  
 
Laboratory measurements  
Blood samples were drawn in the morning after a 10-12 hours fast. Participants without known diabetes underwent a 
75g 2-h oral glucose tolerance test and those with known diabetes had fasting plasma glucose measured. Plasma 
glucose, serum total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C), low density lipoprotein 
cholesterol (LDL-C), ALT, aspartate aminotransferase (AST) and uric acid were measured using an automated clinical 
chemistry analyser (UnicelDxC 800; Beckman Coulter, Miami, FL, USA). Hemoglobin A1c (HbA1c) was measured 
using cation-exchange high pressure liquid chromatography (Adams A1c HA-8160; Arkray, Kyoto, Japan) which 
conform to the Diabetes Control and Complications Trial standards. Serum hepatitis B virus surface antigen and 
hepatitis C antibodies were tested using an enhanced chemiluminescence assays (Ortho-Clinical Diagnostics, NJ, 
USA). 
 
Definition of diseases or conditions 
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 Known diabetes was defined by a self-reported history of diabetes diagnosed by a doctor and/or on glucose lowering 
treatment. Undiagnosed diabetes was defined as fasting plasma glucose (FPG) ≥ 7.0mmol/l and/or 2-h plasma glucose 
(2-hPG) ≥ 11.1mmol/l17. Impaired glucose tolerance (IGT) was defined as FPG < 7.0 mmol/l and 7.8 ≤ 2-hPG < 11.1 
mmol/l. Impaired fasting glucose (IFG) was defined as 6.1 ≤ FPG < 7.0mmol/l and 2-hPG < 7.8 mmol/l. Normal glucose 
tolerance was defined as FPG < 6.1 mmol/l and 2-hPG < 7.8mmol/l17. 
Overweight was defined as BMI between 23.0 and 27.49 kg/m2, and obesity as BMI ≥ 27.5 kg/m2 according to the 
World Health Organization Asian-specific BMI cut points18. According to the International Diabetes Federation criteria in 
200519, central obesity was defined by waist circumference ≥ 90cm for men or ≥ 80cm for women19. Metabolic 
syndrome was defined if central obesity plus any two of the following four components were present: (1) Triglycerides ≥ 
1.7 mmol/l, (2) HDL-C < 1.03 mmol/l in men or < 1.29 mmol/l in women, (3) Systolic blood pressure ≥ 130 mmHg or 
diastolic blood pressure ≥ 85 mmHg or treatment of previously diagnosed hypertension, (4) Fasting plasma glucose ≥ 
5.6 mmol/l or previously diagnosed Type 2 diabetes19.  
 
Abnormal CT scan and definition of NAFLD 
Individuals underwent unenhanced abdominal CT scan using a 64-slice multidetector scanner (LightSpeed VCT, 
General Electric Healthcare, Milwaukee, WI, USA). Continuous 5mm thick slices (120kVp, 120-150mA) from the lung 
base to the pubic symphysis were acquired in the supine position. The Hounsfield Units (HU) of three 1cm2 areas from 
liver avoiding vessels and two areas in spleen were measured similar to what was done in the Framingham Heart 
Study20,21. The mean of the liver and spleen measurements was used to calculate the L/S ratios. NAFLD was defined 
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 as L/S ratio ≤ 1.18. 
 
Statistical analysis 
Statistical analyses were performed using SPSS for Windows, version22 (SPSS, Inc., Chicago, IL). Continuous 
variables with normal distribution were presented as means ± SD and compared using t-tests. Variables with skewed 
distribution were presented as median (25th, 75th percentage) and compared using Mann-Whitney U tests. Categorical 
data were presented as number and percentage and compared using Chi squared tests. A multivariable logistic 
regression model was used to estimate the odds ratio and its 95% confidence interval [OR (95%CI)] of candidate 
factors for prevalent NAFLD. Interaction between annual house income and alcohol consumption, PA level or red meat 
intake in men and interaction between post-menopausal status and PA level or red meat intake in women were 
examined. The difference was considered significant if the p-value of interaction was P< 0.05. 
 
Results 
NAFLD prevalence and associated factors 
The prevalence of NAFLD was 26.5% (95% CI 24.1, 29.0), 20.1% (95% CI 18.4, 22.0) and 22.6% (95% CI 21.2, 24.1) 
in men, women and men and women together in the overall study population, respectively. Individuals with NAFLD 
were more obese, hypertensive, hyperglycemic, hyperuricemic and had a higher proportion of individuals with 
hypertriglycemia and metabolic syndrome and a lower proportion of individuals with a high PA level. They had higher 
ALT and AST levels and more individuals with NAFLD consumed red meat above the median level. A higher proportion 
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 of men with NAFLD had an annual household income ≥ 75000CNY. Women with NAFLD had a higher concentration of 
total cholesterol, higher proportion of post-menopausal status and lower proportion of them had received a college or 
higher education (Table1). Only 16.9% individuals with NAFLD (23.5% men and 11.3% women) had an abnormal ALT > 
40 U/l.  
The prevalence of NAFLD in men aged 26-35, 36-45, 46-55, 56-65 and ≥ 66yrs was 31.0%, 29.4%, 22.9%, 26.1% and 
23.1% [P for the category (Pcat) was 0.171], respectively, and in women it was 17.5%, 14.0%, 19.9%, 25.9% and 24.6 
(Pcat < 0.001), respectively (Figure1). Younger men aged ≤ 45 yrs have a higher prevalence than older men aged > 45 
yrs (30.1% vs. 24.2%, P=0.021) whereas younger women aged ≤ 45 yrs have a lower prevalence of NAFLD compared 
to older women aged > 45yrs (15.2% vs. 22.8%, P < 0.001). Men who consumed more red meat had a higher 
prevalence of NAFLD only in 46-55 yrs age group (P=0.003). Women who consumed more or less red meat had a 
similar prevalence of NAFLD in each age group. Alcohol drinkers and non-drinkers had a similar prevalence of NAFLD 
in each age group in men (Figure2). The prevalence of NAFLD between women alcohol drinkers and non-drinkers in 
each age group was not compared due to the small number of women drinkers in some categories. 
 
Cardiovascular risk factors across the spectrum of NAFLD 
Men and women were categorized into groups according to L/S ratio. There were 181 (14.6%), 119 (9.6%), 177 
(14.3%), 252 (20.4%), 181 (14.6%), 135 (10.9%), 92 (7.4%) and 101 (8.2%) men with L/S ratio > 1.5, > 1.4 - ≤ 1.5, > 
1.3 - ≤1.4, > 1.2 - ≤ 1.3, > 1.1 - ≤ 1.2, > 1.0 - ≤ 1.1, > 0.9 - ≤ 1.0 and ≤ 0.9, respectively, and for women, they were 286 
(14.8%), 232 (12.0%), 346 (17.9%), 370 (19.2%), 306 (15.9%), 181 (9.4%), 81 (4.2%) and 126 (6.5%), respectively.  
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 The prevalence of metabolic complications of obesity, diabetes and metabolic syndrome began to increase at a cutoff 
of L/S ratio ≤ 1.1 in both men and women (Figure3).  
 
Factors independently associated with NAFLD 
Increased age was associated with a decreased risk of having NAFLD in men [OR 0.87 (95%CI 0.77-0.99), model1 in 
Table2], and an increased risk in women [1.22 (1.09-1.36), model1 in Table2]. However, the association was no longer 
significant after adjustment for BMI or waist circumference, systolic blood pressure HbA1c, total cholesterol, 
hypertriglycerides and uric acid (model2 in Table2, model1 in Table S1). In the full model (model3 in Table2, model2 in 
Table S1) which was fitted with post-menopausal status (for women), annual household income, education background, 
PA level, smoking status (for men), red meat intake and alcohol drinking, increased BMI, waist circumference, HbA1c, 
elevated serum triglycerides and ALT were independently associated with the presence of NAFLD in both men and 
women. Increased systolic blood pressure and annual household income ≥ 75000 CNY were independently associated 
with the presence of NAFLD in men, whereas, increased uric acid, low PA level and red meat intake ≥ 200g/week were 
independently associated with the presence of NAFLD in women. Low/moderate alcohol consumption did not 
statistically significantly increase or decrease the odds of NAFLD in this population (Table 2).  
We tested whether annual house income and alcohol consumption (P=0.804), PA level (P=0.425) or red meat intake 
(P=0.550) in men and post-menopausal status and PA level (P=0.449) or red meat intake (P=0.096) in women 
non-linearly increased the prevalence of NAFLD using interaction modeling, but none were statistically significant.  
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 There were 10 women and 5 men who had other data except for CT scan. As compared with the 3166 participants 
included in the study, participants who did not perform CT scan were younger (40.5 vs. 49.7 yrs, P=0.003). No 
significant differences were found in BMI (25.2 vs. 26.1 kg/m2, P=0.344), systolic blood pressure (122 vs. 129 mmHg, 
P=0.122) and fasting blood glucose (5.9 vs. 6.1 mmol/l, P=0.662). 
Discussion 
Our study showed 26.5% men and 20.1% women had NAFLD in Pinggu China. Men aged ≤ 45yrs or women aged > 
45yrs were more likely to have NAFLD than their older/younger counterparts respectively. Obesity, hyperglycemia, 
hypertriglycemia and high ALT concentration were all independently associated with the presence of NAFLD in both 
men and women. High annual household income and systolic blood pressure for men and low physical activity level 
and high serum uric acid and consumption of red meat for women were also independent risk factors for the presence 
of NAFLD.  
Our finding that NAFLD is prevalent in an Asian population and associates with metabolic diseases is consistent with 
other reported studies21-23. In a Caucasian population, the Framingham Offspring and the Third Generation study, the 
prevalence of fatty liver detected by CT was 19%, 15% and 17% in men, women and the whole study population, 
respectively21. Individuals with NAFLD in Pinggu had a lower BMI on average than individuals in Framingham but were 
about the same average age21. This result is consistent with observations that individuals of Asian ancestry develop 
metabolic disease at lower BMIs than individuals of European ancestry24. We found that obesity, hyperglycemia, high 
blood pressure and hypertriglycerides were all associated with NAFLD as also noted in Caucasian21,25 and Asian23,26 
populations. Our study, however, also identified demographic and dietary factors as contributing to the disease 
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 independently of metabolic factors. In particular, we found that high intake of red meat was independently associated 
with NAFLD in women. Two small sample-sized studies reported a higher intake of meat11 or red meat27 increased the 
risk of the presence of NAFLD. However, these two studies did not take gender into consideration when observing the 
association between red meat intake and NAFLD.  
To our knowledge, this is the first large population-based study in Chinese people using unenhanced abdominal CT 
scan to detect NAFLD. Our findings that fatty liver is prevalent and associates with metabolic disease support that CT 
can reliably measure NAFLD in an Asian population. CT based quantitation of liver fat is correlated (r=0.92) with 
histologic based fatty infiltration28. It is less expensive and clinically more widely available than proton MRS currently 
and less operator dependent and accurate than ultrasound29. The L/S ratio provided a more accurate evaluation for 
liver fat content than ultrasound. Further, we show that only 16.9% of those with NAFLD had abnormally elevated 
 ALT (> 40 U/l) suggesting that ALT is not a good marker of the disease despite its widespread use. 
From a public health perspective, our results suggest screening, prevention and intervention strategies for NAFLD 
should be focused on young and middle-aged men as well as elder women who were at a higher risk of NAFLD in this 
cohort. Our data demonstrate that an L/S ratio≤1.1 is an appropriate cutoff point for discriminating a population with a 
higher prevalence of metabolic disorders in both men and women. Thus, screening for metabolic disorders in 
individuals found to have a low L/S ratio on abdominal CT should be considered. 
Moreover, our study provides current information on the prevalence of NAFLD in men and women from a largely 
unmedicated general population in mainland China. In this study, although men and women had similar prevalence of 
obesity defined by BMI, NAFLD is more prevalent in men than in women, consistent with one previous report22. Such a 
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 result is consistent with the fact that a higher proportion of men than women had metabolic complications of obesity, 
specifically hypertriglycemia and diabetes. In several studies26,30,31, the prevalence of NAFLD increased as age 
increased in women and only one study among the above31 showed the same result in men. The other two studies26,30 
including ours showed the peak prevalence of NAFLD in young or middle-aged men. The reason why the peak 
prevalence of NAFLD differs between men and women is not clear. In our study, the peak in NAFLD prevalence in men 
corresponded with increased sedentary behavior, increased alcohol consumption, increased eating of red meat, and 
high household income. Only high household income, however independently associated with NAFLD in men in a 
multivariate model. This variable although clearly not pathophysiologically plausible, may best capture behaviors such 
as alcohol consumption, increased sedentary behavior, and eating red meat that could be more directly contributing to 
NAFLD pathophysiology in men. Although we identified distinct unique demographic determinants that independently 
correlated with NAFLD in men versus women, we cannot rule out that biological variables also contributed to the 
differences between men and women and can be studied through future work on the genetics of NAFLD in this 
population.  
Strength of the current study includes that it is the largest non-medicated population-based study using CT scanning to 
measure NAFLD in Asia. The study is also contemporary and focuses on a region undergoing rapid gentrification which 
allowed us to capture a wide diversity of exposures to be able to identify demographic and dietary factors that also 
associate with NAFLD. Limitations include that this region may not be representative of all of China and that based on 
cross-sectional data we cannot infer causality between associated factors and NAFLD. Although we excluded 
individuals with excess alcohol drinking from the analysis and controlled for any residual alcohol consumption using 
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 regression, we cannot rule out that there was under reporting of drinking which may have contributed to fatty liver on 
CT scanning. We do not see a protection from development of fatty liver with low levels of alcohol consumption as 
some have reported32.  
In conclusion, we found that 26.5% men and 20.1% women had NAFLD in Pinggu, China. NAFLD was independently 
associated with obesity, hyperglycemia, hypertriglycemia and elevated ALT in both men and women. Higher annual 
household income and blood pressure for men and higher serum uric acid, lower physical activity level and higher red 
meat intake for women were also independently associated with NAFLD in multivariate models. An L/S ratio≤1.1 
indicated a high risk of metabolic disorders in general populations and individuals with such findings on CT scanning 
may want to be screened for concomitant metabolic disease.  
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Figure1 Prevalence of non-alcoholic fatty liver disease (NAFLD) and 95%CI according to age in men and women 
Pcat was for the difference among age groups using a Chi squared test. 
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Figure2 Prevalence of NAFLD by red meat consumption and alcohol drinking according to age and sex 
Red meat consumption ≥ median indicates ≥ 325g/w for men and ≥ 200g/w for women; * P=0.003 for the difference 
between red meat consumption ≥ median and < median in men ages 45-55. 
 
 
Figure3 Percentage of metabolic disorders in men and women according to liver spleen ratio 
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 Overweight indicates BMI 23.0-27.49 kg/m2, and obesity indicates BMI ≥27.5 kg/m2; IGT/IFG, impaired glucose 
tolerance and/or impaired fasting glucose; Pcat was for the difference among liver-spleen ratio groups using a Chi 
squared test. 
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 Table1 Characteristics of men and women according to with or without non-alcoholic fatty liver disease 
 Men    Women    
 Total Non-NAFLD NAFLD P value Total Non-NAFLD NAFLD P value 
N (%) 1238 910 (73.5) 328 (26.5)  1928 1540 (79.9) 388 (20.1)  
Age (year) 49.1±12.4 49.6±12.3 47.9±12.5 0.034 50.0±11.6 49.5±11.6 51.8±11.4 < 0.001 
BMI (kg/m2) 26.1±3.8 25.6±3.5 27.5±4.1 < 0.001 26.1±4.0 25.6±3.7 28.0±4.2 < 0.001 
BMI (kg/m2) category    < 0.001    < 0.001 
  ﹤23.0 254 (20.5) 211 (23.2) 43 (13.1)  426 (22.1) 381 (24.7) 45 (11.6)  
  23.0-27.49 564 (45.6) 442 (48.6) 122 (37.2) 0.122 856 (44.4) 722 (46.9) 134 (34.5) 0.014 
   ≥ 27.5 420 (33.9) 257 (28.2) 163 (49.7) < 0.001 646 (33.5) 437 (28.4) 209 (53.9) < 0.001 
Waist 
circumference(cm) 
89.1±10.3 87.9±9.8 92.7±10.7 < 0.001 84.3±10.8 82.9±10.1 90.0±11.5 < 0.001 
≥ 90cm in men or ≥ 
80cm in women 
607 (49.0) 395 (43.4) 212 (64.6) < 0.001 1241 (64.4) 928 (60.3) 313 (80.7) < 0.001 
Systolic blood 
pressure (mmHg) 
130±16 129±16 133±17 < 0.001 128±19 127±19 133±19 < 0.001 
Diastolic blood 
pressure (mmHg) 
80±11 79±11 82±12 0.001 76±11 76±10 79±12 < 0.001 
Glucose tolerance     < 0.001    < 0.001 
   Normal 673 (54.4) 546 (60.0) 127 (38.7)  1107 (57.4) 980 (63.6) 127 (32.7)  
   IGT/IFG 301 (24.3) 206 (22.6) 95 (29.0) < 0.001 507 (26.3) 370 (24.0) 137 (35.3) < 0.001 
   Previously 
undiagnosed diabetes 
117 (9.5) 65 (7.1) 52 (15.9) < 0.001 138 (7.2) 76 (4.9) 62 (16.0) < 0.001 
   Known diabetes 147 (11.9) 93 (10.2) 54 (16.5) < 0.001 176 (9.1) 114 (7.4) 62 (16.0) < 0.001 
FPG (mmol/l) 6.3±1.9 6.2±1.8 6.6±2.0 < 0.001 5.9±1.5 5.8±1.3 6.5±1.9 < 0.001 
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 HbA1c (%) 5.9±1.0 5.8±1.0 6.1±1.1 < 0.001 5.8±0.9 5.7±0.8 6.2±1.1 < 0.001 
Total cholesterol 
(mmol/l) 
4.8±0.9 4.8±0.9 4.8±1.1 0.368 5.0±1.0 4.9±1.0 5.2±1.0 < 0.001 
Triglycerides ≥ 1.7 
mmol/l  
410 (33.1) 254 (27.9) 156 (47.6) < 0.001 488 (25.3) 308 (20.0) 180 (46.4) < 0.001 
HDL-C (mmol/l) 1.05±0.28 1.08±0.28 0.99±0.26 < 0.001 1.21±0.29 1.23±0.28 1.13±0.30 < 0.001 
LDL-C (mmol/l) 2.83±0.81 2.83±0.80 2.83±0.83 0.994 2.92±0.82 2.90±0.81 3.01±0.85 0.017 
ALT (U/l) 23 (17,31) 22 (17,28) 28 (20,40) < 0.001 17 (14,23) 17 (14,21) 23 (16,31) < 0.001 
ALT (U/l) by quartile    < 0.001    < 0.001 
   < 17 (men) or < 14 
(women) 
242 (19.5) 201 (22.1) 41 (12.5)  383 (19.9) 348 (22.6) 35 (9.0)  
   17-22 (men) or 
14-16 (women) 
356 (28.8) 294 (32.3) 62 (18.9) 0.880 473 (24.5) 408 (26.5) 65 (16.8) 0.038 
   23-30 (men) or 
17-22 (women) 
324 (26.2) 233 (25.6) 91 (27.7) 0.002 583 (30.2) 489 (31.8) 94 (24.2) 0.002 
   ≥ 31 (men) or ≥ 23 
(women) 
316 (25.5) 182 (20.0) 134 (40.9) < 0.001 489 (25.4) 295 (19.2) 194 (50.0) < 0.001 
AST (U/l) 22 (19,25) 21 (18,25) 23 (19,28) < 0.001 20 (18,24) 20 (18,23) 22 (19,27) < 0.001 
Uric acid (umol/l) 322±78 317±76 337±83 < 0.001 249±62 241±59 278±65 < 0.001 
Metabolic syndrome 503 (40.6) 314 (34.5) 189 (57.6) < 0.001 925 (48.0) 650 (42.2) 275 (70.9) < 0.001 
Post-menopausal 
status 
- - - - 977 (50.7) 745 (48.4) 232 (59.8) < 0.001 
Annual household 
income (CNY)  
   0.001    0.926 
   < 25000 178 (14.4) 145 (15.9) 33 (10.1)  429 (22.3) 341 (22.1) 88 (22.7)  
This article is protected by copyright. All rights reserved.
    25000-74999 688 (55.6) 514 (56.5) 174 (53.0) 0.061 1061 (55.0) 853 (55.4) 208 (53.6) 0.691 
≥ 75000  349 (28.2) 232 (25.5) 117 (35.7) < 0.001 388 (20.1) 306 (19.9) 82 (21.1) 0.827 
Didn’t report 23 (1.9) 19 (2.1) 4 (1.2) 0.894 50 (2.6) 40 (2.6) 10 (2.6) 0.932 
Education    0.119    0.003 
Elementary school 
or lower 
153 (12.4) 118 (13.0) 35 (10.7)  475 (24.6) 360 (23.4) 115 (29.6)  
Middle school 864 (69.8) 641 (70.4) 223 (68.0) 0.442 1197 (62.1) 959 (62.3) 238 (61.3) 0.051 
College or higher 221 (17.9) 151 (16.6) 70 (21.3) 0.064 256 (13.3) 221 (14.4) 35 (9.0) 0.001 
Physical activity level    0.021    0.064 
    Low 176 (14.2) 119 (13.1) 57 (17.4)  106 (5.5) 86 (5.6) 20 (5.2)  
    Moderate 484 (39.1) 346 (38.0) 138 (42.1) 0.335 735 (38.1) 567 (36.8) 168 (43.3) 0.358 
    High 578 (46.7) 445 (48.9) 133 (40.5) 0.013 1087 (56.4) 887 (57.6) 200 (51.5) 0.905 
Smoking†    0.317    - 
   Non-smoker 306 (24.7) 221 (24.3) 85 (25.9)  1909 (99.0) 1521 (98.8) 388 (100.0)  
   Ex-smoker 237 (19.1) 167 (18.4) 70 (21.3) 0.653 3 (0.2) 3 (0.2) 0 (0.0) - 
   Current-smoker 695 (56.1) 522 (57.4) 173 (52.7) 0.336 16 (0.8) 16 (1.0) 0 (0.0) - 
Red meat intake by 
median (g/week)  
   0.062    0.037 
   ≥ 325 (men) or ≥ 
200 (women) 
621 (50.2) 442 (48.6) 179 (54.6)  1022 (53.0) 798 (51.8) 224 (57.7)  
Alcohol drinking 
(g/week) 
   0.775    0.379 
    0 412 (33.3) 308 (33.8) 104 (31.7)  1741 (90.3) 1386 (90.0) 355 (91.5)  
    0.1-140 for men 
or 0.1-70 for women 
695 (56.1) 506 (55.6) 189 (57.6) 0.477 164 (8.5) 137 (8.9) 27 (7.0) 0.231 
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 140.1-210 for 
men or 70.1-140 for 
women 
131 (10.6) 96 (10.5) 35 (10.7) 0.736 23 (1.2) 17 (1.1) 6 (1.5) 0.503 
Data were expressed as means ± SD for continuous data with normal distribution, median (25th, 75th percentage) for 
continuous data with skewed distribution and n (%) for categorical data.  
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; IGT/IFG, impaired glucose tolerance and/or impaired 
fasting glucose; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-C, high density lipoprotein cholesterol; 
LDL-C, low density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CNY, 
China Yuan. 
P value was for the difference between the non-NAFLD and NAFLD using t test for normal distributed data, 
Mann-Whitney U test for skewed distributed data and Chi square test for categorical data. For multicategorical 
variables p-value taken from univariate logistic regression models comparing the categories to the lowest category in 
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 Table2 Odds ratio (95% CI) for non-alcoholic fatty liver disease of candidate factors corresponding to a one standard 
deviation increase in continuous variables and categorical data as indicated using logistic regression analysis 
 Men   Women   
 Model1 Model2 Model3 Model1 Model2 Model3 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age (years) 0.87 (0.77, 0.99) 1.00 (0.86, 1.17) 1.02 (0.86, 1.21) 1.22 (1.09, 1.36) 0.88 (0.76, 1.03) 0.84 (0.66, 1.06) 
BMI (kg/m2)  1.26 (1.08, 1.47) 1.23 (1.05, 1.44)  1.30 (1.13, 1.48) 1.27 (1.11, 1.45) 
Systolic blood 
pressure (mmHg) 
 1.18 (1.03, 1.36) 1.22 (1.05, 1.41)  1.05 (0.91, 1.21) 1.07 (0.92, 1.24) 
HbA1c (%)  1.26 (1.11, 1.44) 1.26 (1.11, 1.44)  1.28 (1.15, 1.44) 1.29 (1.15, 1.44) 
Total cholesterol 
(mmol/l) 
 0.89 (0.78, 1.02) 0.90 (0.78, 1.03)  1.00 (0.88, 1.14) 1.00 (0.88, 1.13) 
Triglycerides ≥ 1.7 
vs. <1.7 mmol/l 
 1.60 (1.19, 2.15) 1.58 (1.17, 2.13)  2.15 (1.65, 2.81) 2.13 (1.62, 2.79) 
ALT (U/l)       
   <17 (men) or 
<14 (women) 
 1.00  1.00   1.00  1.00  
   17-22 (men) or 
14-16 (women) 
 0.86 (0.55, 1.35) 0.85 (0.54, 1.33)  1.28 (0.81, 2.02) 1.28 (0.81, 2.02) 
   23-30 (men) or 
17-22 (women) 
 1.37 (0.88, 2.12) 1.38 (0.89, 2.14)  1.17 (0.75, 1.81) 1.16 (0.75, 1.81) 
   ≥ 31 (men) or ≥ 
23 (women) 
 2.29 (1.46, 3.58) 2.30 (1.46, 3.62)  3.56 (2.34, 5.42) 3.57 (2.33, 5.47) 
Uric acid (umol/l)  1.14 (0.99, 1.31) 1.13 (0.98, 1.31)  1.44 (1.27, 1.63) 1.44 (1.27, 1.64) 
Post-menopausal 
status yes vs. no 
  -   1.06 (0.70, 1.58) 
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 Annual household 






   <25000   1.00    1.00  
   25000-74999   1.36 (0.85, 2.18)   1.05 (0.76, 1.46) 
   ≥ 75000   1.96 (1.15, 3.34)   1.41 (0.91, 2.18) 
   Didn’t report   0.70 (0.20, 2.39)   0.92 (0.40, 2.10) 
Education       
Elementary 
school or lower 
 
 
1.00   
 
1.00  





0.79 (0.43, 1.46)  
 




     
    High   1.00    1.00  
    Moderate   1.30 (0.86, 1.96)   1.23 (0.70, 2.18) 
    Low   1.05 (0.78, 1.43)   1.35 (1.04, 1.75) 
Smoking       
   Non-smoker   1.00    - 
   Ex-smoker   1.04 (0.70, 1.56)   - 




0.92 (0.66, 1.27)  
 - 
Red meat intake ≥ 
325 vs. < 325 
(men) or ≥ 200 vs. 
 
 
1.00 (0.76, 1.33)  
 
1.41 (1.09, 1.82) 
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    0  
 
1.00   
 
1.00  
    0.1-140 for 




0.93 (0.69, 1.27)  
 
0.91 (0.57, 1.46) 
140.1-210 for 




0.98 (0.60, 1.59)  
 
1.33 (0.45, 3.86) 
BMI, body mass index; HbA1c, hemoglobin A1c; ALT, alanine aminotransferase; CNY, China Yuan. 
Model1 fitted with Age 
Model2 fitted with Model1+BMI, Systolic blood pressure, HbA1c, total cholesterol, triglycerides, ALT and uric acid 
Model3 fitted with Model2 + post-menopausal status (for women), annual house income, education level, physical 
activity level, smoking status (for men), red meat intake and alcohol consumption 
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